Riverwater Partners’s Globus Medical GMED Stock Holding History

Riverwater Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,408	Closed	-$207K	–	219
2026 Q1	$207K	Buy	2,408 +9	+0.4%	+$808	0.07%	207
2025 Q4	$209K	Buy	+2,399	New	+$182K	0.08%	205

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Riverwater Partners's GMED Position: Q2 2026 in Review

Riverwater Partners sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 2,408 shares — an estimated $207K sold.

Riverwater Partners first reported a position in GMED in Q4 2025 and held it in 2 quarters. The position peaked at $209K in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Riverwater Partners reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Riverwater Partners sold 2,408 Globus Medical shares in Q2 2026, an estimated $207K.
Riverwater Partners first reported a position in Globus Medical in Q4 2025 and held it in 2 quarters.
Riverwater Partners's Globus Medical position peaked at $209K in Q4 2025.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.